Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eschmann

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocolThomas Hehr, Godehard Friedel, Volker Steger, et al.
Nuklearmedizin. Nuclear Medicine|March 30, 2007
Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter studyH Stergar, A Bockisch, S M Eschmann, et al.
AJR. American Journal of Roentgenology|August 20, 2002
Giant bilateral inflammatory pseudotumor arising along the arterial sheath of the lower extremitiesMarius Horger, Markus Müller-Schimpfle, Manfred Wehrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapyS M Eschmann, G Friedel, F Paulsen, et al.
Abdominal Imaging|May 14, 2005
Dual-phase multidetector thin-section CT in detecting duodenal gastrinomaA C Pfannenberg, C Burkart, S M Kröber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PETSusanne M Eschmann, Gerald Reischl, Kilian Bilger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2006
Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivorsS M Eschmann, G Friedel, F Paulsen, et al.
The British Journal of Radiology|March 3, 2007
Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imagingA C Pfannenberg, P Aschoff, K Brechtel, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 17, 2023
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohortAlexander Brose, Kerstin Michalski, Juri Ruf, et al.
Nuclear Medicine Communications|January 2, 2007
Fixation devices for whole-body 18F-FDG PET/CT: patient perspectives and technical aspectsKlaus Brechtel, Henriette Heners, Marc Mueller, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocolThomas Hehr, Godehard Friedel, Volker Steger, et al.
Nuklearmedizin. Nuclear Medicine|March 30, 2007
Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter studyH Stergar, A Bockisch, S M Eschmann, et al.
AJR. American Journal of Roentgenology|August 20, 2002
Giant bilateral inflammatory pseudotumor arising along the arterial sheath of the lower extremitiesMarius Horger, Markus Müller-Schimpfle, Manfred Wehrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapyS M Eschmann, G Friedel, F Paulsen, et al.
Abdominal Imaging|May 14, 2005
Dual-phase multidetector thin-section CT in detecting duodenal gastrinomaA C Pfannenberg, C Burkart, S M Kröber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PETSusanne M Eschmann, Gerald Reischl, Kilian Bilger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2006
Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivorsS M Eschmann, G Friedel, F Paulsen, et al.
The British Journal of Radiology|March 3, 2007
Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imagingA C Pfannenberg, P Aschoff, K Brechtel, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 17, 2023
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohortAlexander Brose, Kerstin Michalski, Juri Ruf, et al.
Nuclear Medicine Communications|January 2, 2007
Fixation devices for whole-body 18F-FDG PET/CT: patient perspectives and technical aspectsKlaus Brechtel, Henriette Heners, Marc Mueller, et al.
Pageof 4